Together with his team and strategic collaboration partners from industry, Horst Lindhofer developed the first trifuctional antibody from scratch to EMEA approval.

undefinedLearn more about Horst Lindhofer’s background

For further informations please contact us at:

 

LINDIS Biotech
Am Klopferspitz 19
82152 Martinsried


CEO: Dr. Horst Lindhofer


Tel: +49 89 - 700766 24
Fax: +49 89 - 700766 11
mail [at] lindisbiotech.de